Merck MRK announced that a phase study evaluating its Daiichi Sankyo-partnered HER3-directed DXd antibody drug conjugate (ADC ...

Merck and Daiichi Sankyo's HER3 antibody-drug conjugate reported a positive phase 3 result in EGFR-mutated lung cancer. Merck ...

Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what its prospects are for the next ...

What's the BIOSECURE Act? Why is Merck nonchalant about Summit's Keytruda rival? What did Roivant buy from Bayer? We answer ...

Adding a novel, ultra-long-acting biologic to standard care for patients with severe asthma and type 2 inflammation ...

Immune checkpoint inhibitors are the superheroes of cancer therapy. | Immune checkpoint inhibitors are the superheroes of ...

The final product processing segment is further categorized as small-molecule processing and biologics processing ...

Along with breast cancer, cervical cancer is among the most feared cancer diagnoses for women around the world.

Pharmaceutical companies are making investments in research of therapies that target three different antigen-binding sites.

Meniscus Tear Clinical Trial Progression: The market is poised for substantial growth, fueled by the anticipated launch of ...

Morgan Stanley 22nd Annual Global Healthcare Conference September 5, 2024 2:35 PM ETCompany ParticipantsRob Davis ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...